151 related articles for article (PubMed ID: 24459835)
1. Tigecycline susceptibility in multidrug resistant Acinetobacter isolates from Turkey.
Yilmaz FF; Taşli H; Gül-Yurtsever S; Büyük A; Hoşgör-Limoncu M
Pol J Microbiol; 2013; 62(3):295-8. PubMed ID: 24459835
[TBL] [Abstract][Full Text] [Related]
2. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.
Jones RN; Ferraro MJ; Reller LB; Schreckenberger PC; Swenson JM; Sader HS
J Clin Microbiol; 2007 Jan; 45(1):227-30. PubMed ID: 17093026
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
Eser OK; Ergin A; Tunçkanat F; Hasçelik G
New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
[TBL] [Abstract][Full Text] [Related]
4. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
Al-Sweih NA; Al-Hubail MA; Rotimi VO
J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
Piewngam P; Kiratisin P
Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
[TBL] [Abstract][Full Text] [Related]
6. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009).
Sader HS; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Feb; 69(2):223-7. PubMed ID: 21251571
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
Henwood CJ; Gatward T; Warner M; James D; Stockdale MW; Spence RP; Towner KJ; Livermore DM; Woodford N
J Antimicrob Chemother; 2002 Mar; 49(3):479-87. PubMed ID: 11864948
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.
Park YK; Choi JY; Song JH; Ko KS
Int J Antimicrob Agents; 2009 Mar; 33(3):289-90. PubMed ID: 19091518
[No Abstract] [Full Text] [Related]
10. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.
Karageorgopoulos DE; Kelesidis T; Kelesidis I; Falagas ME
J Antimicrob Chemother; 2008 Jul; 62(1):45-55. PubMed ID: 18436554
[TBL] [Abstract][Full Text] [Related]
11. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
Morfin-Otero R; Dowzicky MJ
Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009).
Mendes RE; Farrell DJ; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):307-11. PubMed ID: 20955916
[TBL] [Abstract][Full Text] [Related]
13. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
Navon-Venezia S; Leavitt A; Carmeli Y
J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
[TBL] [Abstract][Full Text] [Related]
14. Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.
Kulah C; Celebi G; Aktas E; Mengeloglu Z; Comert F; Ankarali H
J Chemother; 2009 Aug; 21(4):390-5. PubMed ID: 19622456
[TBL] [Abstract][Full Text] [Related]
15. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N
J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of tigecycline in clinical isolates of multidrug resistant Acinetobacter spp. Comparison of different methods of evaluation].
Zárate MS; Serruto G; Smayevsky J
Rev Argent Microbiol; 2010; 42(1):53-6. PubMed ID: 20461296
[TBL] [Abstract][Full Text] [Related]
17. Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
Curcio D; Fernández F; Jones RN; Ferraro MJ; Reller LB; Schreckenberger PC; Sader HS
J Clin Microbiol; 2007 Jun; 45(6):2095; author reply 2095-6. PubMed ID: 17548459
[No Abstract] [Full Text] [Related]
18. EVALUATION OF IN VITRO TIGECYCLINE ACTIVITY AGAINST MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII CLINICAL ISOLATES FROM POLAND.
Paluchowska P; Nowak P; Skalkowska M; Bjdak A
Acta Pol Pharm; 2017 May; 74(3):793-800. PubMed ID: 29513948
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods.
Liao CH; Kung HC; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Cheng YJ; Lin HC; Shi ZY; Wang LS; Chuang YC; Tsao SM; Lu CT; Liu JW; Huang CH; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S192-6. PubMed ID: 19013354
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia.
Dhabaan GN; AbuBakar S; Shorman MA; Hassan H
J Chemother; 2012 Apr; 24(2):87-92. PubMed ID: 22546763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
